vs
Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Bio-Techne (TECH). Click either name above to swap in a different company.
DIVERSIFIED HEALTHCARE TRUST is the larger business by last-quarter revenue ($379.6M vs $295.9M, roughly 1.3× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -5.6%, a 18.4% gap on every dollar of revenue. On growth, DIVERSIFIED HEALTHCARE TRUST posted the faster year-over-year revenue change (-0.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 1.2%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DHC vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $379.6M | $295.9M |
| Net Profit | $-21.2M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -12.6% | 18.4% |
| Net Margin | -5.6% | 12.8% |
| Revenue YoY | -0.0% | -6.4% |
| Net Profit YoY | 75.7% | 68.3% |
| EPS (diluted) | $-0.09 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $379.6M | $295.9M | ||
| Q3 25 | $388.7M | — | ||
| Q2 25 | $382.7M | $317.0M | ||
| Q1 25 | $386.9M | $316.2M | ||
| Q4 24 | $379.6M | $297.0M | ||
| Q3 24 | $373.6M | $289.5M | ||
| Q2 24 | $371.4M | $306.1M | ||
| Q1 24 | $370.8M | $303.4M |
| Q4 25 | $-21.2M | $38.0M | ||
| Q3 25 | $-164.0M | — | ||
| Q2 25 | $-91.6M | $-17.7M | ||
| Q1 25 | $-9.0M | $22.6M | ||
| Q4 24 | $-87.4M | $34.9M | ||
| Q3 24 | $-98.7M | $33.6M | ||
| Q2 24 | $-97.9M | $40.6M | ||
| Q1 24 | $-86.3M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | -12.6% | 18.4% | ||
| Q3 25 | -43.4% | — | ||
| Q2 25 | -24.5% | -7.5% | ||
| Q1 25 | -2.7% | 12.2% | ||
| Q4 24 | -26.1% | 16.0% | ||
| Q3 24 | -26.5% | 13.8% | ||
| Q2 24 | -23.0% | 15.0% | ||
| Q1 24 | -23.7% | 22.1% |
| Q4 25 | -5.6% | 12.8% | ||
| Q3 25 | -42.2% | — | ||
| Q2 25 | -23.9% | -5.6% | ||
| Q1 25 | -2.3% | 7.1% | ||
| Q4 24 | -23.0% | 11.7% | ||
| Q3 24 | -26.4% | 11.6% | ||
| Q2 24 | -26.3% | 13.3% | ||
| Q1 24 | -23.3% | 16.2% |
| Q4 25 | $-0.09 | $0.24 | ||
| Q3 25 | $-0.68 | — | ||
| Q2 25 | $-0.38 | $-0.11 | ||
| Q1 25 | $-0.04 | $0.14 | ||
| Q4 24 | $-0.37 | $0.22 | ||
| Q3 24 | $-0.41 | $0.21 | ||
| Q2 24 | $-0.41 | $0.26 | ||
| Q1 24 | $-0.36 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $105.4M | $172.9M |
| Total DebtLower is stronger | $2.4B | $260.0M |
| Stockholders' EquityBook value | $1.7B | $2.0B |
| Total Assets | $4.4B | $2.5B |
| Debt / EquityLower = less leverage | 1.47× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.4M | $172.9M | ||
| Q3 25 | $201.4M | — | ||
| Q2 25 | $141.8M | $162.2M | ||
| Q1 25 | $302.6M | $140.7M | ||
| Q4 24 | $144.6M | $177.5M | ||
| Q3 24 | $256.5M | $187.5M | ||
| Q2 24 | $265.6M | $152.9M | ||
| Q1 24 | $207.1M | $145.3M |
| Q4 25 | $2.4B | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $3.1B | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $1.7B | $2.0B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.9B | $1.9B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $2.1B | $2.1B | ||
| Q1 24 | $2.2B | $2.0B |
| Q4 25 | $4.4B | $2.5B | ||
| Q3 25 | $4.7B | — | ||
| Q2 25 | $4.8B | $2.6B | ||
| Q1 25 | $5.0B | $2.6B | ||
| Q4 24 | $5.1B | $2.7B | ||
| Q3 24 | $5.3B | $2.7B | ||
| Q2 24 | $5.3B | $2.7B | ||
| Q1 24 | $5.3B | $2.7B |
| Q4 25 | 1.47× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 1.56× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.6M | — |
| Free Cash FlowOCF − Capex | $-166.4M | — |
| FCF MarginFCF / Revenue | -43.8% | — |
| Capex IntensityCapex / Revenue | 38.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-280.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-19.6M | — | ||
| Q3 25 | $-49.3M | — | ||
| Q2 25 | $53.0M | $98.2M | ||
| Q1 25 | $-3.2M | $41.1M | ||
| Q4 24 | $112.2M | $84.3M | ||
| Q3 24 | $21.1M | $63.9M | ||
| Q2 24 | $44.3M | $75.5M | ||
| Q1 24 | $28.6M | $81.0M |
| Q4 25 | $-166.4M | — | ||
| Q3 25 | $-89.8M | — | ||
| Q2 25 | $18.8M | $93.3M | ||
| Q1 25 | $-42.9M | $31.0M | ||
| Q4 24 | $-89.5M | $77.5M | ||
| Q3 24 | $-26.1M | $54.7M | ||
| Q2 24 | $3.3M | $57.5M | ||
| Q1 24 | $-18.1M | $64.5M |
| Q4 25 | -43.8% | — | ||
| Q3 25 | -23.1% | — | ||
| Q2 25 | 4.9% | 29.4% | ||
| Q1 25 | -11.1% | 9.8% | ||
| Q4 24 | -23.6% | 26.1% | ||
| Q3 24 | -7.0% | 18.9% | ||
| Q2 24 | 0.9% | 18.8% | ||
| Q1 24 | -4.9% | 21.3% |
| Q4 25 | 38.7% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.9% | 1.5% | ||
| Q1 25 | 10.2% | 3.2% | ||
| Q4 24 | 53.1% | 2.3% | ||
| Q3 24 | 12.6% | 3.2% | ||
| Q2 24 | 11.0% | 5.9% | ||
| Q1 24 | 12.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
